1. Home
  2. UVE vs CTMX Comparison

UVE vs CTMX Comparison

Compare UVE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$36.91

Market Cap

957.6M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.56

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
CTMX
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.6M
977.1M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
UVE
CTMX
Price
$36.91
$3.56
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$40.00
$12.10
AVG Volume (30 Days)
156.4K
2.9M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
1.97%
N/A
EPS Growth
214.43
N/A
EPS
1.88
N/A
Revenue
$1,603,915,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.88
$7.61
P/E Ratio
$20.02
$22.58
Revenue Growth
5.48
N/A
52 Week Low
$21.96
$1.72
52 Week High
$41.96
$8.21

Technical Indicators

Market Signals
Indicator
UVE
CTMX
Relative Strength Index (RSI) 40.68 36.09
Support Level $32.51 $3.40
Resistance Level $41.32 $3.91
Average True Range (ATR) 1.16 0.18
MACD -0.45 0.01
Stochastic Oscillator 1.98 21.58

Price Performance

Historical Comparison
UVE
CTMX

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: